Drug comparisons
Alogliptin vs Tolbutamide
Alogliptin vs. Tolbutamide: Compare DPP-4 inhibitor and sulfonylurea for type 2 diabetes. Key differences in side effects, efficacy, and hypoglycemia risk explained.
No comparison dimensions are available for this page.
Clinical context
This comparison is typically triggered when considering a switch from older first-generation sulfonylureas to newer DPP-4 inhibitors for improved safety in type 2 diabetes.
Bottom line
Alogliptin often provides a better safety profile than Tolbutamide for most patients, though neither is universally superior.
All medication comparisons